Cancer treatments as paradoxical catalysts of tumor awakening in the lung

Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024). Cancer statistics, 2024. CA: A Cancer Journal for Clinicians, 74(1), 12–49.

PubMed  Google Scholar 

Massagué, J., & Ganesh, K. (2021). Metastasis-initiating cells and ecosystems. Cancer Discovery, 11(4), 971–994.

Article  PubMed  PubMed Central  Google Scholar 

Borriello, L., et al. (2022). Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells. Nature Communications, 13(1), 626.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goddard, E. T., et al. (2018). Dormant tumour cells, their niches and the influence of immunity. Nature Cell Biology, 20(11), 1240–1249.

Article  CAS  PubMed  Google Scholar 

Pu, Y., et al. (2023). Drug-tolerant persister cells in cancer: The cutting edges and future directions. Nature Reviews. Clinical Oncology, 20(11), 799–813.

Article  PubMed  Google Scholar 

Kim, K., Marquez-Palencia, M., & Malladi, S. (2019). Metastatic latency, a veiled threat. Frontiers in Immunology, 10, 1836.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klein, C. A. (2020). Cancer progression and the invisible phase of metastatic colonization. Nature Reviews Cancer, 20(11), 681–694.

Article  CAS  PubMed  Google Scholar 

Pan, H., et al. (2017). 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. New England Journal of Medicine, 377(19), 1836–1846.

Article  PubMed  Google Scholar 

Pedersen, R. N., et al. (2022). The incidence of breast cancer recurrence 10–32 years after primary diagnosis. Journal of the National Cancer Institute, 114(3), 391–399.

Article  PubMed  Google Scholar 

Aguirre-Ghiso, J. A. (2021). Translating the science of cancer dormancy to the clinic. Cancer Research, 81(18), 4673–4675.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jamil, A., & Kasi, A. (2024). Lung metastasis, in StatPearls, StatPearls Publishing opyright © 2024, StatPearls Publishing LLC.: Treasure Island (FL).

Stella, G. M. et al. (2019). Lung-seeking metastases. Cancers (Basel), 11(7), 1010.

Hiam-Galvez, K. J., Allen, B. M., & Spitzer, M. H. (2021). Systemic immunity in cancer. Nature Reviews Cancer, 21(6), 345–359.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perdrix Rosell, A., et al. (2022). Early functional mismatch between breast cancer cells and their tumour microenvironment suppresses long term growth. Cancer Letters, 544, 215800.

Article  CAS  PubMed  Google Scholar 

Altea-Manzano, P., et al. (2023). A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling. Nature Cancer, 4(3), 344–364.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krausgruber, T., et al. (2020). Structural cells are key regulators of organ-specific immune responses. Nature, 583(7815), 296–302.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Monteran, L., Zait, Y., & Erez, N. (2024). It's all about the base: Stromal cells are central orchestrators of metastasis. Trends in Cancer, 10(3), 208–229.

Sahai, E., et al. (2020). A framework for advancing our understanding of cancer-associated fibroblasts. Nature Reviews Cancer, 20(3), 174–186.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park, S. Y., & Nam, J. S. (2020). The force awakens: Metastatic dormant cancer cells. Experimental & Molecular Medicine, 52(4), 569–581.

Article  CAS  Google Scholar 

Klevorn, L. E., & Teague, R. M. (2016). Adapting cancer immunotherapy models for the real world. Trends in Immunology, 37(6), 354–363.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Franceschi, C., et al. (2000). Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences, 908, 244–54.

Article  CAS  PubMed  Google Scholar 

Schmauck-Medina, T., et al. (2022). New hallmarks of ageing: A 2022 Copenhagen ageing meeting summary. Aging (Albany NY), 14(16), 6829–6839.

Article  PubMed  Google Scholar 

Schneider, J. L., et al. (2021). The aging lung: Physiology, disease, and immunity. Cell, 184(8), 1990–2019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McQuattie-Pimentel, AC. et al. (2021). The lung microenvironment shapes a dysfunctional response of alveolar macrophages in aging. The Journal of Clinical Investigation, 131(4), e140299.

Lowy, D. R., et al. (2022). Treating smoking in cancer patients: An essential component of cancer care-The New National Cancer Institute Tobacco Control Monograph. JCO Oncology Practice, 18(12), e1971–e1976.

Article  PubMed  PubMed Central  Google Scholar 

Sparrock, L. S., et al. (2023). Nicotine pouch: Awareness, beliefs, use, and susceptibility among current tobacco users in the United States, 2021. International Journal of Environmental Research and Public Health, 20(3), 2050.

Mark, N. M., et al. (2018). Chronic obstructive pulmonary disease alters immune cell composition and immune checkpoint inhibitor efficacy in non-small cell lung cancer. American Journal of Respiratory and Critical Care Medicine, 197(3), 325–336.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takahashi, H., et al. (2010). Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell, 17(1), 89–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan, S., et al. (2021). Effects of smoking on inflammatory markers in a healthy population as analyzed via the gut microbiota. Frontiers in Cellular and Infection Microbiology, 11, 633242.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shapiro, H., et al. (2022). Smoking-induced microbial dysbiosis in health and disease. Clinical Science (London, England), 136(18), 1371–1387.

Article  CAS  Google Scholar 

NCD Risk Factor Collaboration (NCD-RisC) (2024). Worldwide trends in underweight and obesity from 1990 to 2022: A pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet, 403(10431), 1027–1050.

Quail, D. F., et al. (2017). Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF. Nature Cell Biology, 19(8), 974–987.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McDowell, S. A. C. et al. (2023). Obesity alters monocyte developmental trajectories to enhance metastasis. Journal of Experimental Medicine, 220(8).

Swaby, A., et al. (2023). Lifestyle and host determinants of antitumor immunity and cancer health disparities. Trends Cancer, 9(12), 1019–1040.

Article  CAS  PubMed  Google Scholar 

Rybinski, B., Franco-Barraza, J., & Cukierman, E. (2014). The wound healing, chronic fibrosis, and cancer progression triad. Physiological Genomics, 46(7), 223–244.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shaked, Y. (2019). The pro-tumorigenic host response to cancer therapies. Nature Reviews Cancer, 19(12), 667–685.

Article  CAS  PubMed  Google Scholar 

Pang, L., et al. (2022). Postoperative plasmacytoid dendritic cells secrete IFNα to promote recruitment of myeloid-derived suppressor cells and drive hepatocellular carcinoma recurrence. Cancer Research, 82(22), 4206–4218.

留言 (0)

沒有登入
gif